openPR Logo
Press release

Asthma Market to witness Impressive Growth by 2032, Examines DelveInsight | Companies- Avillion LLP, GlaxoSmithKline, AstraZeneca, Akeso Biopharma, Sterna Biologics and Others

11-25-2022 01:24 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Asthma Market

Asthma Market

DelveInsight's "Asthma Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Asthma Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Asthma market report covers emerging drugs, treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Asthma: An Overview
Asthma is a chronic lung disease that makes breathing difficult. When the symptoms suddenly get worse, it results in an asthma attack. As of now, there's no cure for asthma; however, with the proper treatment plan, its symptoms can easily control. Sometimes, it can cause trouble while talking or doing physical activities.

Asthma Market Key Facts
• In the United States, more than 25 million people have asthma. Which is nearly equal to 7.7 percent of adults and 8.4 percent of children.
• As per the WHO, It was estimated that more than 339 million people had Asthma globally in 2016. It is a common disease among children.

Asthma Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current and forecasted Asthma market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Asthma market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Discover How Asthma Market will Grow by 2032:
https://www.delveinsight.com/report-store/asthma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Asthma Epidemiology
The epidemiology section covers detailed insights into the historical and current Asthma patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032.

Get Key Insights Into the Evolving Asthma Epidemiology Trends:
https://www.delveinsight.com/report-store/asthma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Asthma Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Asthma market or expected to get launched in the market during the study period. The analysis covers Asthma market uptake by drugs, patient uptake by therapies, and sales of each drug.

Report's Drugs Uptake section helps in understanding the drugs with the most rapid uptake and reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Asthma Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Ongoing Pipeline Development Activities:
https://www.delveinsight.com/sample-request/asthma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Asthma Therapeutics Assessment
Some of the key companies in the Asthma Therapeutics Market include:
• Avillion LLP
• GlaxoSmithKline
• AstraZeneca
• Akeso Biopharma
• Sterna Biologics
• T-Balance therapeutics
• Chia Tai Tianqing Pharmaceutical Group
• Kinaset therapeutics
• SAREPTA THERAPEUTICS
• Landos Biopharma
• Aslan Pharmaceuticals
• Tarus therapeutics
And many others

Asthma Therapies covered in the report include:
• PT027
• GSK3511294
• BGF MDI
• AK120
• SB010
• Tregalizumab
• TQC2731
• KN-002
• SRP-6004
• LABP-73
• ASLAN004
• A2BR inhibitors (Research programme)
And many more

Learn More About the Emerging Therapies & Key Companies in the Asthma Therapeutics Market:
https://www.delveinsight.com/sample-request/asthma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Asthma Competitive Intelligence Analysis
4. Asthma Market Overview at a Glance
5. Asthma Disease Background and Overview
6. Asthma Patient Journey
7. Asthma Epidemiology and Patient Population
8. Asthma Treatment Algorithm, Current Treatment, and Medical Practices
9. Asthma Unmet Needs
10. Key Endpoints of Asthma Treatment
11. Asthma Marketed Products
12. Asthma Emerging Therapies
13. Asthma Seven Major Market Analysis
14. Attribute Analysis
15. Asthma Market Outlook (7 major markets)
16. Asthma Access and Reimbursement Overview
17. KOL Views on the Asthma Market.
18. Asthma Market Drivers
19. Asthma Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/asthma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Contact Info:
Ankit Nigam
Email: info@delveinsight.com
Request for Sample Copy of the Report at:
https://www.delveinsight.com/sample-request/asthma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asthma Market to witness Impressive Growth by 2032, Examines DelveInsight | Companies- Avillion LLP, GlaxoSmithKline, AstraZeneca, Akeso Biopharma, Sterna Biologics and Others here

News-ID: 2822285 • Views: 251

More Releases from DelveInsight Business Research

Oropharyngeal cancer Pipeline Appears Robust With 10+ Key Pharma Companies Activ …
DelveInsight's, "Oropharyngeal Cancer Pipeline Insight, 2023," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Oropharyngeal Cancer pipeline landscape. It covers the Oropharyngeal Cancer pipeline drug profiles, including Oropharyngeal Cancer clinical trials and nonclinical stage products. It also covers the Oropharyngeal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. In the
House Dust Mite Allergy Pipeline Appears Robust With 5+ Key Pharma Companies Act …
DelveInsight's, "House Dust Mite Allergy Pipeline Insight, 2023," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in House Dust Mite Allergy pipeline landscape. It covers the House Dust Mite Allergy pipeline drug profiles, including House Dust Mite Allergy clinical trials and nonclinical stage products. It also covers the House Dust Mite Allergy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further
X-Linked Retinitis Pigmentosa Pipeline Appears Robust With 5+ Key Pharma Compani …
DelveInsight's, "X-linked Retinitis Pigmentosa Pipeline Insight, 2023," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in X-linked Retinitis Pigmentosa pipeline landscape. It covers the X-Linked Retinitis Pigmentosa pipeline drug profiles, including X-Linked Retinitis Pigmentosa clinical trials and nonclinical stage products. It also covers the X-Linked Retinitis Pigmentosa pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products
Tourette Syndrome Market to Grow at a Substantial Growth Rate During the Forecas …
As per DelveInsight, the Tourette Syndrome Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases, the continuous improvement in the research and development activities by the major pharmaceutical giants, and the launch of emerging therapies in the market. DelveInsight's "Tourette Syndrome Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as

All 5 Releases


More Releases for Asthma

Asthma Treatment Market: Increase in Prevalence of Asthma and Rise in Awareness …
Transparency Market Research (TMR) has published a new report on the asthma treatment market for the forecast period of 2019–2027. According to the report, the global asthma treatment market was valued at ~US$ 25 Bn in 2018, and is projected to expand at a CAGR of ~2% from 2019 to 2027. Read Report Overview - https://www.transparencymarketresearch.com/asthma-treatment-market.html Overview Asthma treatment involves two main types of medications: long-term asthma control medications and quick-relief (rescue) medications. Asthma
Anti-Asthma Drugs Market Factors Affecting Market Growth 2018 | Key Type of Asth …
To Track and Analyze Competitive Developments such as Joint Ventures, Strategic Alliances, Mergers and Acquisitions, New Product Developments, and Research and Developments Globally. The all things added in “Global Anti Asthma Drugs Market Research Report – Forecast to 2022” – Avail Prime Report to MRFR Anti-Asthma Drugs Market - Overview With the air pollution rising around the world, the number of asthma patients is also increasing. Therefore the market for the drugs
Asthma-Pipeline Review H2 2017
ReportsWeb.com published “Asthma” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Asthma-Pipeline Review, H2 2017, provides an overview of the Asthma (Respiratory) pipeline landscape. Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow
Landmark Asthma Study Demonstrates Device Choice Determines Asthma Control
Monaghan Medical Corporation understands that for those with asthma, particularly children, choosing the device that best delivers their medication is an important consideration. Plattsburgh, NY, USA -- Monaghan Medical Corporation understands that for those with asthma, particularly children, choosing the device that best delivers their medication is an important consideration. Research has shown that even when using the same metered-dose inhaler (MDI), not all valved holding chambers perform equally well.[1] A landmark
Asthma-Pipeline Review H2 2017
ReportsWeb.com published “Asthma” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Asthma-Pipeline Review, H2 2017, provides an overview of the Asthma (Respiratory) pipeline landscape. Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow
Asthma Therapeutics Market to 2020 - Personalized Treatment for Severe Asthma to …
Recent Research, a leading business intelligence provider, has released its latest research report: “Asthma Therapeutics Market to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations.” The asthma therapeutics market is forecast to grow marginally over the forecast period across the top eight developed nations, from $18.4 billion in 2013 to a projected value of $21.7 billion by 2020 at a Compound Annual Growth Rate (CAGR)